The 30-Month Stay: How Patent Litigation Blocks Generic Drug Approval
The 30-month stay delays generic drug approval when brand makers sue over patents. Learn how this Hatch-Waxman provision works, its economic impact, and proposed reforms.
The 30-month stay delays generic drug approval when brand makers sue over patents. Learn how this Hatch-Waxman provision works, its economic impact, and proposed reforms.